TikTok CEO predicts major AI-driven scientific breakthroughs in three years
by@CNBC
Summary
At the DBS Asia Future Forward Conference in Singapore, TikTok CEO Shou Zi Chew expressed optimism that artificial intelligence (AI) will lead to significant scientific breakthroughs within the next three years, citing potential advancements in fields such as physics, biotech, and chemistry. His statements come as ByteDance, TikTok's parent company, expands its AI research efforts, particularly in biomolecular structure prediction, which has implications for drug discovery. Chew highlighted the urgent need for aligning AI systems with human ethical expectations while acknowledging the cybersecurity risks associated with increasingly sophisticated AI.
Analysis
TikTok: TikTok is a global short-form video platform operated by ByteDance that focuses on content creation, recommendation algorithms, search, and moderation. Its CEO Shou Zi Chew highlighted AI's expanding role in reshaping these core operations during recent public remarks. The platform's parent company is actively exploring AI applications that extend beyond consumer features into scientific research. ByteDance: ByteDance is the Chinese technology company that owns and operates TikTok while developing its own artificial intelligence models and research initiatives. The company has expanded its AI work beyond consumer applications, including the Seed research team's recent unveiling of Protenix-v2 for biomolecular structure prediction and design with potential drug discovery uses. ByteDance is also pursuing collaborations with external scientists to advance scientific progress through AI. Shou Zi Chew: Shou Zi Chew serves as CEO of TikTok and has publicly shared views on the accelerating capabilities of artificial intelligence. He spoke at the DBS Asia Future Forward Conference in Singapore, emphasizing AI's potential for major scientific breakthroughs in fields such as physics, biotech, chemistry, and material science within the next two to three years. Chew also addressed the need for better model alignment, ethical safeguards, and cybersecurity measures as AI systems gain greater autonomy. AI Research Expansion: ByteDance is extending its artificial intelligence efforts into scientific domains such as biomolecular structure prediction to support applications like drug discovery. Industry Collaboration: Technology companies are partnering with government and research entities on AI models designed to advance biological research and accelerate drug discovery. Scientific Discovery Focus: AI is increasingly viewed as a promising tool for fundamental scientific progress, with ongoing work to integrate it into research beyond its current consumer and operational uses.
Categories
aitechmachine_learning